In This Section

CICR Communications Subcommittee

Martin E. Swarbrick, PhD
Chair

Martin E. Swarbrick, PhD

(2022-2024)

Director of R&D Chemistry
Ryvu Therapeutics SA
Krakow, Poland

Keith R. Hornberger, PhD
Past Chair

Keith R. Hornberger, PhD

(2022-2023)

Director, Chemistry
Arvinas
, Inc.
New Haven, Connecticut

Barbara Czako, PhD

Barbara Czako, PhD

(2021-2023)

Principal Scientist, Therapeutics Discovery
MD Anderson Cancer Center
 
Houston, Texas

Dennis X. Hu, PhD

Dennis X. Hu, PhD

(2021-2023)

Senior Scientist, Small Molecule Drug Discovery
Genentech

South San Francisco, California 

Lyn Howard Jones, PhD

Lyn Howard Jones, PhD

(2021-2023)

Chief Scientist, Center for Protein Degradation
Dana-Farber Cancer Institute
 
Boston, Massachusetts 

Milka Kostic, PhD

Milka Kostic, PhD

(2022-2024)

Program Director, Chemical Biology
Training Curriculum Director, Cancer Chemical Biology and Metabolism
Department of Cancer Biology
Dana-Farber Cancer Institute
Boston, Massachusetts